Iodine has been used as a wound antiseptic for centuries. It is an exceptionally effective antimicrobial agent that kills all germs, including bacteria, viruses and fungi. However, in its natural form, it can also cause unwanted effects.
In the 1950s, researchers discovered that by combining natural iodine with a polymer, called povidone or PVP, the iodine could be used safely on the skin. The new compound was called povidone-iodine or simply PVP-I. Since then and for more than 6 decades, PVP-I solutions have been widely used in hospitals as antiseptics to prevent and treat infection during and after surgery.
Recently, it was discovered that at low concentrations (about 1/10th of the concentration used in hospital antiseptics), PVP-I can be used safely in the nose without compromising its rapid germ-killing properties. It is this discovery that insipired the development of Nasodine® Nasal Spray.
Nasodine is a topical antiseptic for nasal use and can be used for degerming the nasal passages whenever you feel concerned about germs. You might consider using Nasodine after exposure to crowds while commuting, traveling on holidays, at public gatherings, and at work.
Nasodine was developed by Firebrick Pharma Ltd, an Australian biotechnology company founded in 2012 with the mission to create a nasal spray based on PVP-I (povidone-iodine). After more than 10 years of R&D, including multiple clinical trials, that product is now a reality and is called Nasodine Nasal Spray. Nasodine combines the rapid broad-spectrum antiseptic properties of PVP-I with a formula that has been shown to be safe for nasal use.
Nasodine is manufactured in Australia exclusively for Firebrick Pharma. Nasodine is a registered international trademark owned by Firebrick Pharma and the product is protected by multiple international patents.